About 1 result found for searched term "Nimotuzumab" (0.168 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1512 | Nimotuzumab | EGFR/HER2 |
| CAS# 780758-10-3 | ||
| Nimotuzumab (Nimotuzumab) is the first humanized monoclonal antibody targeting epidermal growth factor receptor (EGFR). Nimotuzumab has cytolytic effects on target tumors through its ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC). Nimotuzumab failed to recognize mouse EGFR. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
